Xilio Therapeutics, Inc.

Pharmaceutical Preparations

NASDAQ.XLO

828 Winter Street, Waltham, MA, 02451

Latest Filings – Non-Ownership

Results Of Operations And Financial Condition, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing

Results Of Operations And Financial Condition, Financial Statements And Exhibits

08 Aug 24

8-K

Submission Of Matters To A Vote Of Security Holders

17 Jun 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers

13 Jun 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Notice Of Effectiveness For A Previously Filed Sec Document.

06 May 24

S-3

Registration Statement Under The Securities Act.

30 Apr 24

ARS

Scanned Paper Annual Report Submission.

25 Apr 24

DEFA14A

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

25 Apr 24

DEF 14A

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

25 Apr 24

424B5

Prospectus Filed Pursuant To Rule 424(b)(5).

15 Apr 24

S-8

Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.

Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.

01 Apr 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

01 Apr 24

8-K

Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Cost Associated With Exit Or Disposal Activities, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

28 Mar 24

Latest Filings – Non-Ownership

8-K

Results Of Operations And Financial Condition, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing

Results Of Operations And Financial Condition, Financial Statements And Exhibits

08 Aug 24

8-K

Submission Of Matters To A Vote Of Security Holders

17 Jun 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers

13 Jun 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Notice Of Effectiveness For A Previously Filed Sec Document.

06 May 24

S-3

Registration Statement Under The Securities Act.

30 Apr 24

ARS

Scanned Paper Annual Report Submission.

25 Apr 24

DEFA14A

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

25 Apr 24

DEF 14A

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

25 Apr 24

424B5

Prospectus Filed Pursuant To Rule 424(b)(5).

15 Apr 24

S-8

Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.

Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.

01 Apr 24

8-K

Results Of Operations And Financial Condition, Financial Statements And Exhibits

01 Apr 24

8-K

Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Cost Associated With Exit Or Disposal Activities, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

28 Mar 24

Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.

Latest Filings – Non-Ownership

Latest Filings – Ownership

Latest Filings – Non-Ownership

Latest Filings – Ownership